However, the WHO saf since become less definitive in estimating the scope of the s?k?nt?, kak?m there is an inherent difficulty in quantifying copyright products, which have become increasingly sophisticated and difficult to differentiate from genuine medicines. In a 2016 statement, the WHO stated that “The copyright drug market is a nebulous a